Correlation Between Merck and Pharma Bio

Can any of the company-specific risk be diversified away by investing in both Merck and Pharma Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Merck and Pharma Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Merck Company and Pharma Bio Serv, you can compare the effects of market volatilities on Merck and Pharma Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Merck with a short position of Pharma Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Merck and Pharma Bio.

Diversification Opportunities for Merck and Pharma Bio

0.71

Correlation Coefficient

Merck  Pharma Bio

Poor diversification

The 3 months correlation between Merck and Pharma is 0.71. Overlapping area represents the amount of risk that can be diversified away by holding Merck Company and Pharma Bio Serv in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pharma Bio Serv and Merck is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Merck Company are associated (or correlated) with Pharma Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pharma Bio Serv has no effect on the direction of Merck i.e., Merck and Pharma Bio go up and down completely randomly.

Pair Corralation between Merck and Pharma Bio

Considering the 90-day investment horizon Merck Company is expected to under-perform the Pharma Bio. But the stock apears to be less risky and, when comparing its historical volatility, Merck Company is 5.73 times less risky than Pharma Bio. The stock trades about -0.19 of its potential returns per unit of risk. The Pharma Bio Serv is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest  64.00  in Pharma Bio Serv on September 17, 2024 and sell it today you would lose (9.00) from holding Pharma Bio Serv or give up 14.06% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	98.46%
Values	Daily Returns

Merck Company  vs.  Pharma Bio Serv

Merck Company

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Merck Company has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in January 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Pharma Bio Serv

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Pharma Bio Serv has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Pharma Bio is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Pair Trading with Merck and Pharma Bio

The main advantage of trading using opposite Merck and Pharma Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Merck position performs unexpectedly, Pharma Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pharma Bio will offset losses from the drop in Pharma Bio's long position.

The idea behind Merck Company and Pharma Bio Serv pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.